Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says
US FDA's preclinical policies should be 'more closely matched to the complexion of modern technologies,' commissioner explains.
US FDA's preclinical policies should be 'more closely matched to the complexion of modern technologies,' commissioner explains.